Endonovo Therapeutics Inc (ENDV)

[sello]

ENDV had a daily move of 999% in December of 2015. Went from .10 to .9999. What preceded that move was the only other time that Mann was buying in the open market. His buying then was nothing even remotely close to what he has been doing on a daily basis for the last 6 months. My personal belief is that what is coming first has nothing to do with the preclinicals. They have been stacking the deck.

They have brought back Ramiro Contreras who was instrumental in the formation of Endonovo, a part of the company during the acquisition of all Rudd's patents and businesses as well as IP resources and putting Alan Collier as CEO. He has come back this time in an executive position.

They have brought in additional IR support hiring Gary Restanio in June 2017 and have set up what appears to be a call station in Mann's home town of Irwin Pennsylvania and I have personally reached voicemail boxes of two different females identifying themselves as with Endonovo Therapeutics when calling the office number.

This looks to me to be outside of the scope of would be needed for simply releasing preclinicals.

Did I mention Mann's buying?

This is going to be something big and it would make good business sense to release before Oct. 7th as that is the date that Eagle can begin converting the first note from April.

I have amassed a healthy position here playing the highs and lows but right now I am in 100% lockdown mode. You might get shares here but you won't get mine. GLTA